AIM ImmunoTech, Inc.
(NYSE Amex Equities : AIM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -10.46%143.320.0%$1329.52m
AMGNAmgen, Inc. -1.58%224.131.4%$504.67m
NVAXNovavax, Inc. -14.08%72.7478.2%$499.37m
BIIBBiogen, Inc. -0.95%218.421.8%$492.04m
GILDGilead Sciences, Inc. -0.42%68.221.0%$489.94m
REGNRegeneron Pharmaceuticals, Inc. -1.68%610.992.7%$395.99m
BNTXBioNTech SE -4.85%140.350.0%$393.46m
ILMNIllumina, Inc. -4.40%349.843.3%$362.18m
VRTXVertex Pharmaceuticals, Inc. -1.96%223.611.9%$334.27m
SNSSSunesis Pharmaceuticals, Inc. -4.91%2.520.7%$176.16m
EXASEXACT Sciences Corp. -7.92%68.1717.9%$155.31m
ARNAArena Pharmaceuticals, Inc. -0.27%90.2413.7%$131.02m
INCYIncyte Corp. -1.22%73.882.4%$128.60m
ALNYAlnylam Pharmaceuticals, Inc. -5.25%129.258.2%$118.44m
BMRNBioMarin Pharmaceutical, Inc. -3.04%82.084.2%$100.05m

Company Profile

AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Ocala, FL.